[DISCLOSURE]
Nature Cell (007390) announced Aug. 24 that it has acquired a stake of 25 percent of a patent for the composition that increases the storage safety of blood serum-containing stem cells. The patent originally belonged to Naturecell CEO Ra Jeong-chan.
The company reported this composition will be of a great help in shipping stem cells overseas, including to Japan and Hong Kong.
By Yun Jeong-hyeon (
clareyun@heraldcorp.com)